Chronic Myeloproliferative Disorders Active Not Recruiting Phase 1 / 2 Trials for Pomalidomide (DB08910)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00669578CC-4047 in Treating Patients With MyelofibrosisTreatment